What makes JSI’s approach to capacity strengthening unique is the sincere intent to empower civil society organizations. It’s not just about meeting project requirements and more effectively reaching members of key populations. It is also about building a sustainable foundation for an AIDS-free future in Ghana.
Through the ‘My Choice’ project, JSI has partnered with Indonesia’s National Population & Family Planning Board to reinvigorate family planning services to ensure that women across four provinces have consistent access to a variety of contraceptive options.
Indigenous organizations are critical to mobilizing domestic resources through collaborative advocacy and are in a position to advocate for their governments to promote policies that will benefit their constituents. Furthermore, with extensive experience working with hard-to-reach population groups, civil society organizations often provide services that complement the formal health system and help scale up primary health care services.
In two diverse regions of Burma the Maternal and Child Survival Program and Burma’s Ministry of Health are working together to improve the diagnosis and referral of communicable diseases in vulnerable communities and save children’s lives.
Zambia is making progress toward reaching epidemic control and the global 90–90–90 goals. However, an increasing number of new infections among adolescent girls and young women threatens this and places new importance on finding and reaching their male sexual partners.
JSI HIV expert Helen Cornman shares reflections from the 22nd International AIDS Conference that was held in Amsterdam last month.
JSI expert Angelina Kodua Nyanor writes about the successes our USAID Strengthening the Care Continuum Project has had in ensuring that key populations in Ghana have access to HIV treatment and care services.
Judy Mwangi, senior program manager of DREAMS Innovation Challenge, shares her reflections from the AIDS 2018 conference.
LPV/r pellets are a new, more palatable, and easier-to-administer formulation of a medication for babies and children with HIV. Because of how well they work for pediatric patients, the World Health Organization now recommends LPV/r pellets as the first-line treatment for children 3 months or older, who weigh 5 kilograms or more, and who are able to swallow the pellets with liquid or soft foods.
The global health community is finally realizing that technology is only one piece of a digital health system. Aligning people and processes are just as important, especially given the role that both play in facilitating the uptake of new technology and promoting sustainability.